Celsius (CELH) had the highest return between January 1, 2015 and June 30, 2015 by a US stock with a market cap of $300M to $10B, returning 465.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Celsius (CELH) | 1/1/2015 - 6/30/2015 | 465.87% |
Galapagos NV ADR (GLPG) | 1/1/2015 - 6/30/2015 | 171.68% |
Travere Therapeutics (TVTX) | 1/1/2015 - 6/30/2015 | 168.86% |
Exelixis (EXEL) | 1/1/2015 - 6/30/2015 | 155.78% |
eXp World (EXPI) | 1/1/2015 - 6/30/2015 | 154.1% |
Prothena (PRTA) | 1/1/2015 - 6/30/2015 | 150.81% |
Anavex Life Sciences (AVXL) | 1/1/2015 - 6/30/2015 | 136.84% |
Cardiff Oncology (CRDF) | 1/1/2015 - 6/30/2015 | 134.41% |
Halozyme Therapeutics (HALO) | 1/1/2015 - 6/30/2015 | 131.12% |
Ultragenyx (RARE) | 1/1/2015 - 6/30/2015 | 130.5% |
Nomad Foods (NOMD) | 1/1/2015 - 6/30/2015 | 114.63% |
Quantum Computing (QUBT) | 1/1/2015 - 6/30/2015 | 108.33% |
Repligen (RGEN) | 1/1/2015 - 6/30/2015 | 108.12% |
Immutep Ltd ADR (IMMP) | 1/1/2015 - 6/30/2015 | 107.17% |
Supernus Pharmaceuticals (SUPN) | 1/1/2015 - 6/30/2015 | 102.87% |
CorMedix (CRMD) | 1/1/2015 - 6/30/2015 | 101.04% |
NexGen Energy (NXE) | 1/1/2015 - 6/30/2015 | 99.69% |
Corcept Therapeutics (CORT) | 1/1/2015 - 6/30/2015 | 99.67% |
Ambarella (AMBA) | 1/1/2015 - 6/30/2015 | 97.48% |
Sage Therapeutic (SAGE) | 1/1/2015 - 6/30/2015 | 97.3% |
Frp Holdings Ord (FRPH) | 1/1/2015 - 6/30/2015 | 97.28% |
Esperion Therapeutics (ESPR) | 1/1/2015 - 6/30/2015 | 97.01% |
Globant (GLOB) | 1/1/2015 - 6/30/2015 | 96.96% |
Soleno Therapeutics (SLNO) | 1/1/2015 - 6/30/2015 | 95.14% |
Novavax (NVAX) | 1/1/2015 - 6/30/2015 | 88.81% |
